Mexico City, Mexico

Moises Selman

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas—d.f., The University of Chicago, University of Pittsburgh. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Moises Selman: Innovator in Pulmonary Fibrosis Diagnosis

Introduction

Moises Selman is a prominent inventor based in Mexico City, MX. He has made significant contributions to the field of medical diagnostics, particularly in the area of pulmonary diseases. His work focuses on the diagnosis and evaluation of idiopathic pulmonary fibrosis (IPF), a serious lung condition.

Latest Patents

Selman holds a patent for "Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation." This invention relates to the discovery that a panel of serum or plasma markers can be utilized to diagnose IPF and differentiate it from other lung ailments. Additionally, it identifies markers associated with the progression of IPF disease. He has 1 patent to his name.

Career Highlights

Throughout his career, Selman has worked with prestigious institutions such as the University of Pittsburgh and the University of Chicago. His research has been instrumental in advancing the understanding of pulmonary diseases and improving diagnostic methods.

Collaborations

Some of his notable coworkers include Kevin Gibson and Imre Noth. Their collaborative efforts have contributed to the development of innovative solutions in the field of pulmonary medicine.

Conclusion

Moises Selman's work in the diagnosis of idiopathic pulmonary fibrosis showcases his dedication to medical innovation. His contributions have the potential to significantly impact patient care and improve outcomes for those suffering from this challenging condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…